• Bringing the treatable traits approach to primary care asthma management 

  Pfeffer, PE; Rupani, H; De Simoni, A

• Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry. 

  Scelo, G; Torres-Duque, CA; Maspero, J; Tran, TN; Murray, R; Martin, N; Menzies-Gow, AN; Hew, M; Peters, MJ; Gibson, PG (2023-08-26)

  BACKGROUND: Investigation for the presence of asthma comorbidities is recommended by GINA as their presence can complicate asthma management. OBJECTIVE: To understand the prevalence and pattern of comorbidities and ...

• Efferocytes release extracellular vesicles to resolve inflammation and tissue injury via prosaposin-GPR37 signaling 

  Bhattacharya, P; Dhawan, UK; Hussain, MT; Singh, P; Bhagat, KK; Singhal, A; Austin-Williams, S; Sengupta, S; Subramanian, M (2023)

• Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans (vol 127, pg 169, 2017) 

  Rathod, KS; Kapil, V; Velmurugan, S; Khambata, RS; Siddique, U; Khan, S; Eijl, SV; Gee, LC; Bansal, J; Pitrola, K (2023)

• Determinants of COVID-19 immunisation uptake in a country with high mortality and a low vaccination rate 

  Aksentijevic, D; Tanner, R; Lazovic-Pita, L; Pestek, A; Abdi, A (2023)

• Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study 

  Walker, S; Goodfellow, H; Pookarnjanamorakot, P; Murray, E; Bindman, J; Blandford, A; Bradbury, K; Cooper, B; Hamilton, FL; Hurst, JR (2023)

• Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry. 

  Chen, W; Tran, TN; Sadatsafavi, M; Murray, R; Wong, NCB; Ali, N; Ariti, C; Bulathsinhala, L; Gil, EG; FitzGerald, JM (2023-09)

  BACKGROUND: Effectiveness of biologics has neither been established in patients with high oral corticosteroid exposure (HOCS) nor been compared with effectiveness of continuing with HOCS alone. OBJECTIVE: To examine the ...

• Editorial: Melanocortins and melanocortin receptors in the regulation of inflammation: mechanisms and novel therapeutic strategies 

  Rinne, P; Taylor, AW; Montero-Melendez, T (2023)

• Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma 

  Esposito, I; Kontra, I; Giacomassi, C; Manou-Stathopoulou, S; Brown, J; Stratton, R; Verykokou, G; Buccafusca, R; Stevens, M; Nissim, A (2023)

• Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis. 

  Norling, LV; Headland, SE; Dalli, J; Arnardottir, HH; Haworth, O; Jones, HR; Irimia, D; Serhan, CN; Perretti, M (2023-02-08)

• Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention 

  Dalli, J; Kitch, D; Brien, MP; Hunt, PW; Funderburg, N; Moisi, D; Gupta, A; Brown, TT; Tien, PC; Aberg, JA (2023)

• Correction: A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. 

  Mai, NTH; Dobbs, N; Phu, NH; Colas, RA; Thao, LTP; Thuong, NTT; Nghia, HDT; Hanh, NHH; Hang, NT; Heemskerk, AD (2023-03-21)

• International consensus statement on allergy and rhinology: Allergic rhinitis-2023 

  Wise, SK; Damask, C; Roland, LT; Ebert, C; Levy, JM; Lin, S; Luong, A; Rodriguez, K; Sedaghat, AR; Toskala, E (2023)

• Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK) 

  Tydeman, F; Pfeffer, P; Vivaldi, G; Holt, H; Talaei, M; Jolliffe, D; Davies, G; Lyons, R; Griffiths, C; Kee, F (2022)

• Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both 

  Price, D; pfeffer, P; Ali, N; Murray, R; Ulrik, C; Tran, T; Maspero, J; Peters, M; Christoff, G; Sadatsafavi, M (2022)

• Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy. 

  Louis, R; Harrison, TW; Chanez, P; Menzella, F; Philteos, G; Cosio, BG; Lugogo, NL; de Luiz, G; Burden, A; Adlington, T (2023-06)

  BACKGROUND: The phase IIIb, randomized, parallel-group, placebo-controlled ANDHI double-blind (DB) study extended understanding of the efficacy of benralizumab for patients with severe eosinophilic asthma. Patients from ...

• Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both 

  Pfeffer, PE; Ali, N; Murray, R; Ulrik., C; Tran, TN; Maspero, J; Peters, M; Christoff, GC; Sadatsafavi, M; Torres-Duque, CA (2023)

• Formyl peptide receptor type 2 (FPR2) deficiency in myeloid cells amplifies sepsis-induced cardiac dysfunction 

  Chen, J; Austin-Williams, S; O'Riordan, CE; Claria-Ribas, P; Sugimoto, MA; Norling, LV; Thiemermann, C; Perretti, M (2023)

• Resolving acute inflammation; what happens when inflammation goes haywire? How can it get back in line? 

  Cecconello, C; Clària Ribas, P; Norling, LV (2022-01-01)

  Within this chapter we discuss the mechanisms that drive inflammation resolution and consider the possible reasons for the failure of resolution responses and chronicity of inflammation. We now know that the resolution of ...

• Melanocortin therapies to resolve fibroblast-mediated diseases 

  Khodeneva, N; Sugimoto, MA; Davan-Wetton, CSA; Montero-Melendez, T (2023)

View more